A human monoclonal antibody blocking SARS-CoV-2 infection

Researchers from Utrecht University, together with fellow researchers from Erasmus MC and biotech company Harbor BioMed, have developed a human antibody that can inhibit the new coronavirus (SARS-CoV-2).

Research leader and last author Berend-Jan Bosch (Utrecht University) does not want to raise false expectations. It is a promising first step, but it is far too early to speculate about the potential efficacy in humans. The research is being reviewed by a leading scientific journal.

The complete text is on link: www.biorxiv.org/content/10.1101/2020.03.11.987958v1.full

Read More